From December 1, 2023 to December 25, 2023, the company has repurchased 366,600 shares, representing 0.47% for ¥1,652.25 million. With this, the company has completed the repurchase of 2,000,000 shares, representing 2.58% for ¥9,792.58 million under the buyback announced on July 13, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,774 JPY | -0.55% | -0.11% | -12.46% |
Apr. 11 | Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 | MT |
Jan. 12 | Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.46% | 1.84B | |
+31.36% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.69% | 239B | |
+10.12% | 210B | |
-7.12% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- 4530 Stock
- News Hisamitsu Pharmaceutical Co., Inc.
- Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.